COMP <GO>
ESYN vs MEDS // EV/EBITDA & P/E VALUATION
EnerSyn Global Inc. (NASDAQ) VS. DataMeds AI Inc. (NASDAQ) • 15-METRIC TALLY: ESYN 4
— MEDS 1
■ METRIC PARITY
LAST: $1.83 (+3.10%) • MKT CAP: $54.4M
valuation
—
LAST: $2.03 (-7.73%) • MKT CAP: $9.8M
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ESYN VS. MEDS)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ESYN | MEDS | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 53.00% | -27.50% | +80.50 | ESYN | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -3.25% | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | -60.00% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | -60.00% | -60.00% | 0.00 | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | -30.80% | 28.70% | -59.50 | MEDS | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 2/9 | +2.00 | ESYN | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 58.9 | 38.9 | +19.98 | ESYN | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $54.4M | $9.8M | $44.6M | ESYN | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ESYN REV | MEDS REV | ESYN GROSS % | MEDS GROSS % | ESYN FCF | MEDS FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $866.9K | $23.3M | 53.0% | -27.5% | -$1.8M | -$10.9M |
| FY 2024 | $1.3M | $18.1M | 48.0% | 9.7% | -$1.8M | -$1.2M |
| FY 2023 | $1.2K | $0 | — | — | -$2.6M | -$349.1K |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ESYN // BETA —
MEDS // BETA —